Cargando…
Acetylation in Tumor Immune Evasion Regulation
Acetylation is considered as one of the most common types of epigenetic modifications, and aberrant histone acetylation modifications are associated with the pathological process of cancer through the regulation of oncogenes and tumor suppressors. Recent studies have shown that immune system functio...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645962/ https://www.ncbi.nlm.nih.gov/pubmed/34880761 http://dx.doi.org/10.3389/fphar.2021.771588 |
_version_ | 1784610422409658368 |
---|---|
author | Lu, Jun He, Xiang Zhang, Lijuan Zhang, Ran Li, Wenzheng |
author_facet | Lu, Jun He, Xiang Zhang, Lijuan Zhang, Ran Li, Wenzheng |
author_sort | Lu, Jun |
collection | PubMed |
description | Acetylation is considered as one of the most common types of epigenetic modifications, and aberrant histone acetylation modifications are associated with the pathological process of cancer through the regulation of oncogenes and tumor suppressors. Recent studies have shown that immune system function and tumor immunity can also be affected by acetylation modifications. A comprehensive understanding of the role of acetylation function in cancer is essential, which may help to develop new therapies to improve the prognosis of cancer patients. In this review, we mainly discussed the functions of acetylase and deacetylase in tumor, immune system and tumor immunity, and listed the information of drugs targeting these enzymes in tumor immunotherapy. |
format | Online Article Text |
id | pubmed-8645962 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86459622021-12-07 Acetylation in Tumor Immune Evasion Regulation Lu, Jun He, Xiang Zhang, Lijuan Zhang, Ran Li, Wenzheng Front Pharmacol Pharmacology Acetylation is considered as one of the most common types of epigenetic modifications, and aberrant histone acetylation modifications are associated with the pathological process of cancer through the regulation of oncogenes and tumor suppressors. Recent studies have shown that immune system function and tumor immunity can also be affected by acetylation modifications. A comprehensive understanding of the role of acetylation function in cancer is essential, which may help to develop new therapies to improve the prognosis of cancer patients. In this review, we mainly discussed the functions of acetylase and deacetylase in tumor, immune system and tumor immunity, and listed the information of drugs targeting these enzymes in tumor immunotherapy. Frontiers Media S.A. 2021-11-22 /pmc/articles/PMC8645962/ /pubmed/34880761 http://dx.doi.org/10.3389/fphar.2021.771588 Text en Copyright © 2021 Lu, He, Zhang, Zhang and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Lu, Jun He, Xiang Zhang, Lijuan Zhang, Ran Li, Wenzheng Acetylation in Tumor Immune Evasion Regulation |
title | Acetylation in Tumor Immune Evasion Regulation |
title_full | Acetylation in Tumor Immune Evasion Regulation |
title_fullStr | Acetylation in Tumor Immune Evasion Regulation |
title_full_unstemmed | Acetylation in Tumor Immune Evasion Regulation |
title_short | Acetylation in Tumor Immune Evasion Regulation |
title_sort | acetylation in tumor immune evasion regulation |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645962/ https://www.ncbi.nlm.nih.gov/pubmed/34880761 http://dx.doi.org/10.3389/fphar.2021.771588 |
work_keys_str_mv | AT lujun acetylationintumorimmuneevasionregulation AT hexiang acetylationintumorimmuneevasionregulation AT zhanglijuan acetylationintumorimmuneevasionregulation AT zhangran acetylationintumorimmuneevasionregulation AT liwenzheng acetylationintumorimmuneevasionregulation |